HN2012000142A - Preparación de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1- (2,3-dihidroxipropil)ciclopropan-1-sulfonamida y derivados protegidos de los mismos - Google Patents

Preparación de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1- (2,3-dihidroxipropil)ciclopropan-1-sulfonamida y derivados protegidos de los mismos

Info

Publication number
HN2012000142A
HN2012000142A HN2012000142A HN2012000142A HN2012000142A HN 2012000142 A HN2012000142 A HN 2012000142A HN 2012000142 A HN2012000142 A HN 2012000142A HN 2012000142 A HN2012000142 A HN 2012000142A HN 2012000142 A HN2012000142 A HN 2012000142A
Authority
HN
Honduras
Prior art keywords
difluoro
fluoro
preparation
iodophenylamine
metoxyphenyl
Prior art date
Application number
HN2012000142A
Other languages
English (en)
Inventor
Andreas Maderna
Jean-Michel Vernier
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2012000142(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of HN2012000142A publication Critical patent/HN2012000142A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE RELACIONA CON LA PREPARACION DE (R)-N-(3-4-DIFLORURO-2-(2-FLUORO-4-YODOFENILAMINO)-6-METOXIFENIL)-1-(2,3DIHIDROXIPROPIL)CICLOPROPAN-1-SULFONAMIDA Y (S)-N-(3,4-DIFLUORO-2-(DIFLUORO-4-YODOFENILAMINO)-6-METOXIFENIL)-1-(2,3-DIHIDROXIPROPIL)CICLOPROPAN-1-SULFONAMIDA.
HN2012000142A 2009-07-24 2012-01-24 Preparación de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1- (2,3-dihidroxipropil)ciclopropan-1-sulfonamida y derivados protegidos de los mismos HN2012000142A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24

Publications (1)

Publication Number Publication Date
HN2012000142A true HN2012000142A (es) 2015-06-08

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2012000142A HN2012000142A (es) 2009-07-24 2012-01-24 Preparación de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1- (2,3-dihidroxipropil)ciclopropan-1-sulfonamida y derivados protegidos de los mismos

Country Status (32)

Country Link
US (3) US8513443B2 (es)
EP (1) EP2462111B1 (es)
JP (1) JP5776115B2 (es)
KR (1) KR101763437B1 (es)
CN (2) CN102471246B (es)
AR (1) AR079183A1 (es)
AU (1) AU2010275780B2 (es)
BR (1) BR112012001592A2 (es)
CA (2) CA2768788C (es)
CL (1) CL2012000192A1 (es)
CO (1) CO6491075A2 (es)
CR (1) CR20120044A (es)
CU (1) CU24113B1 (es)
DO (1) DOP2012000017A (es)
EA (1) EA023623B1 (es)
EC (1) ECSP12011621A (es)
GT (1) GT201200017A (es)
HK (2) HK1171218A1 (es)
HN (1) HN2012000142A (es)
IL (1) IL217312A (es)
IN (1) IN2012DN00696A (es)
MA (1) MA33452B1 (es)
MX (2) MX2012001063A (es)
MY (1) MY160421A (es)
NZ (1) NZ597738A (es)
PE (1) PE20120573A1 (es)
PH (1) PH12014500158A1 (es)
SG (1) SG177535A1 (es)
TN (1) TN2012000027A1 (es)
TW (1) TWI524890B (es)
UY (1) UY32800A (es)
WO (1) WO2011009541A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備
KR101939682B1 (ko) * 2011-05-27 2019-01-17 바이엘 인텔렉쳐 프로퍼티 게엠베하 Ｎ-｛3,4-디플루오로-2-〔(2-플루오로-4-요오도페닐)아미노〕-6-메톡시페닐｝-1-[2,3-디하이드록시프로필]사이클로프로판설폰아미드의 키랄 합성
EP2796455A4 (en) * 2011-12-19 2015-08-19 Sumitomo Chemical Co PROCESS FOR PRODUCING SULFONATE
EP2848246A1 (en) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Pharmaceutical compositions containing refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495118B (zh) * 2005-07-21 2012-09-05 阿迪亚生命科学公司 Mek的n-(芳基氨基)磺酰胺抑制剂
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
WO2009018238A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
CA2649122C (en) 2006-04-18 2015-06-30 Ardea Biosciences, Inc. Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
SG189784A1 (en) * 2008-04-14 2013-05-31 Ardea Biosciences Inc Compositions and methods for preparing and using same
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
HK1198364A1 (zh) 2015-04-10
US20130261320A1 (en) 2013-10-03
EP2462111A1 (en) 2012-06-13
BR112012001592A2 (pt) 2016-03-08
IL217312A (en) 2017-02-28
CN102471246A (zh) 2012-05-23
IN2012DN00696A (es) 2015-06-19
NZ597738A (en) 2014-03-28
DOP2012000017A (es) 2012-05-15
PE20120573A1 (es) 2012-05-17
CA2768788C (en) 2018-01-09
CO6491075A2 (es) 2012-07-31
AU2010275780A1 (en) 2012-02-02
US9296686B2 (en) 2016-03-29
MX2012001063A (es) 2012-03-26
AU2010275780B2 (en) 2015-10-22
CU24113B1 (es) 2015-08-27
US8884058B2 (en) 2014-11-11
WO2011009541A1 (en) 2011-01-27
CU20120014A7 (es) 2012-06-21
CA2768788A1 (en) 2011-01-27
EA201200175A1 (ru) 2012-12-28
JP5776115B2 (ja) 2015-09-09
PH12014500158B1 (en) 2015-09-07
MY160421A (en) 2017-03-15
ECSP12011621A (es) 2012-02-29
GT201200017A (es) 2013-12-19
HK1171218A1 (en) 2013-03-22
TWI524890B (zh) 2016-03-11
IL217312A0 (en) 2012-02-29
PH12014500158A1 (en) 2015-09-07
EA023623B1 (ru) 2016-06-30
KR101763437B1 (ko) 2017-07-31
CA2990097A1 (en) 2011-01-27
TW201113017A (en) 2011-04-16
UY32800A (es) 2011-01-31
US20150274651A1 (en) 2015-10-01
CL2012000192A1 (es) 2012-10-05
CN103848808B (zh) 2016-02-10
AR079183A1 (es) 2012-01-04
SG177535A1 (en) 2012-03-29
US8513443B2 (en) 2013-08-20
CN103848808A (zh) 2014-06-11
EP2462111B1 (en) 2016-03-30
CR20120044A (es) 2012-03-12
JP2013500242A (ja) 2013-01-07
KR20120032536A (ko) 2012-04-05
MX344965B (es) 2017-01-12
TN2012000027A1 (en) 2013-09-19
CN102471246B (zh) 2015-08-26
US20120178946A1 (en) 2012-07-12
MA33452B1 (fr) 2012-07-03

Similar Documents

Publication Publication Date Title
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
EA201270254A1 (ru) Производные 5-фторпиримидинона
ECSP10010722A (es) Compuestos orgánicos
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
HN2009001436A (es) Nuevo procedimiento de sintesis de la agometatina
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
IN2012DN00695A (es)
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
EA200800070A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина
HN2012000142A (es) Preparación de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1- (2,3-dihidroxipropil)ciclopropan-1-sulfonamida y derivados protegidos de los mismos
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
ECSP099549A (es) Nuevo procedimiento de síntesis de la agomelatina
BR112013028668A2 (pt) formulações de paracetamol de liberação sustentada
ES2530436T3 (es) Combinación
ECSP11011138A (es) Formulaciones de desintegración rápida pre-compactadas de compuestos con baja biodisponibilidad oral
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives
CO6700896A2 (es) Procesos para la preparación de enaminas
UA106762C2 (uk) Спосіб одержання (r)- та (s)-n-(3,4-дифтор-2-(2-фтор-4-йодфеніламіно)-6-метоксифеніл)-1-(2,3-дигідроксипропіл)циклопропан-1-сульфанаміду та його захищених похідних
HN2008000082A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparacion y aplicacion en terapeutica
UY29691A1 (es) Derivados de n-(arilalquil)-1h-pirrolopiridin-2-carboxamidas, su preparación y su aplicación en terapéutica.